MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study

MJ. Grothe, MA. Labrador-Espinosa, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, E. Iglesias Camacho, P. Franco-Rosado, F. Roldán Lora, JF. Martín-Rodríguez, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, J. Kulisevsky, P. Martínez-Martín, D. Santos-García, P. Mir (Seville, Spain)

Meeting: MDS Virtual Congress 2021

Abstract Number: 833

Keywords: Acetylcholine, Cognitive dysfunction, Magnetic resonance imaging(MRI)

Category: Parkinson's Disease: Neuroimaging

Objective: To assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) integrity and cognition in a well-characterized multicentric cohort of Parkinson’s disease (PD) patients without dementia.

Background: Pronounced atrophy of the CBF is an established neuropathologic feature of dementia in PD, but the degree to which CBF degeneration also relates to more subtle cognitive deficits that emerge in the pre-dementia phase of PD is less well known.

Method: The study included a total of 180 non-demented PD patients and 45 healthy controls, who underwent structural MRI acquisitions and standardized neurocognitive assessment through the PD-Cognitive Rating Scale (PD-CRS) within the multicentric COPPADIS-2015 study. A subset of 73 patients also had Diffusion Tensor Imaging acquisitions. Volumetric and microstructural (mean diffusivity, MD) indices of CBF degeneration were automatically extracted using a stereotactic CBF atlas. For comparison, we also assessed multimodal indices of hippocampal degeneration. Associations between imaging measures and cognitive performance were assessed using linear regression models controlled for acquisition site and total intracranial volume (for volumetric measures), and additional models further controlled for age, sex, education, and motor symptom severity (UPDRS-III scores).

Results: Compared to controls, CBF volume was not significantly reduced in PD patients as a group. However, across PD patients lower CBF volume was significantly associated with lower global cognition (PD-CRStotal: r=0.37, p<0.001; Fig. 1a), and this association remained significant in the fully covariate-controlled model (p=0.003). Analysis of individual PD-CRS item scores showed that this association spanned executive and memory domains. No analogue cognition associations were observed for CBF MD (Fig. 1c). In fully covariate-controlled models, hippocampal volume was not associated with cognition in PD (Fig. 1b), but there was a significant association for hippocampal MD (p=0.042; Fig. 1d).

Conclusion: Early cognitive deficits in PD without dementia are more closely related to structural MRI measures of CBF degeneration than hippocampal degeneration. DTI-based diffusion measures were inferior to standard volumetric assessments for capturing cognition-relevant CBF changes in non-demented PD.

Fig1

To cite this abstract in AMA style:

MJ. Grothe, MA. Labrador-Espinosa, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, E. Iglesias Camacho, P. Franco-Rosado, F. Roldán Lora, JF. Martín-Rodríguez, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, J. Kulisevsky, P. Martínez-Martín, D. Santos-García, P. Mir. In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/in-vivo-cholinergic-basal-forebrain-degeneration-and-cognition-in-parkinsons-disease-imaging-results-from-the-coppadis-study/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/in-vivo-cholinergic-basal-forebrain-degeneration-and-cognition-in-parkinsons-disease-imaging-results-from-the-coppadis-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley